Here, we propose that inhibition of OS by activation of NRF2 improves mitochondrial function, increases the NAD+/NADH ratio, and further activates the downstream protein SIRT3 to maintain mitochondrial energy metabolism to reverse macrophage phenotypic changes, thereby reducing inflammation and tissue damage caused by OS during DN. This evidence concerns the gene SIRT3 and liver dysplastic nodule.